Navigation Links
AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
Date:5/22/2013

Basel, Switzerland (PRWEB) May 22, 2013

Genedata, a leading provider of advanced software solutions for industrial biotechnology, drug discovery, and life science research, today announced AB Enzymes will use Genedata Selector™ as its bioinformatics platform for strain genome data management on all its production-relevant organisms. Genedata will provide AB Enzymes, one of the world’s oldest and best-known enzyme manufacturers, with a hosted solution of Genedata Selector accompanied by bioinformatics consulting services. Genedata Selector, an enterprise genome management solution, streamlines strain optimization and selection through highly automated strain comparison algorithms coupled with efficient data storage capabilities to further safeguard AB Enzymes intellectual property. The solution will serve as centralized data management system connecting AB Enzymes global R&D operations.

“As we look to advance our next-generation sequencing and strain optimization projects we need to integrate our genomics data management and data analysis processes. We looked for a bioinformatics solution that enables us to extract as much information as possible from all available data,” noted Dr. Jari Vehmaanperä, global R&D director at AB Enzymes. “In particular, we wanted a solution to help us better understand underlying genotype-phenotype relationships - Genedata Selector was the clear choice.”

Cost Savings - Time Efficiencies - IP Protection
Genedata Selector analyzes and manages all strain-related data in the context of strain optimization processes. Integrating genomic data with transcriptomics and metabolomics data, Genedata Selector improves gene functional annotation, and provides insights into molecular pathways. Based on sophisticated data analysis algorithms, Genedata Selector establishes genotype-phenotype relationships that enable researchers to efficiently select the most promising strain lines for production. With all experimental data systematically integrated in a single data management system, Genedata Selector supports standardized data analysis workflows across an entire organization. These capabilities contribute to significant cost and time savings while enabling researchers to focus on scientific questions versus manually handling complex data. Moreover, the solution’s intuitive and interactive visualization tools advance efficient decision-making and accelerate Genedata Selector’s time-to-value.

As a hosted solution, Genedata manages the entire Genedata Selector implementation and its ongoing maintenance and support, minimizing a company’s overhead and providing significant cost savings. Inherently efficient, flexible, and secure, the Genedata-hosted model:

  •     Adapts to dynamic business requirements
  • Accelerates implementation time to days vs. weeks
  • Employs latest security protocols to ensure data are safe and only accessible to designated users
  • Enables users from multiple groups and sites to access the system for improved collaboration
  • Ensures – through ongoing monitoring - uninterrupted availability and security of intellectual property (IP)

“We are excited to add AB Enzymes, one of the world’s most successful enzyme companies, to our rapidly growing list of customers in the industrial biotechnology segment,” said Dr. Othmar Pfannes, CEO of Genedata. “AB Enzyme’s adoption of Genedata Selector validates our commitment to and investments in this vital and quickly evolving field. The combination of our domain expertise in bioinformatics and our unique Genedata Selector platform positions us to provide significant value for innovative partners such as AB Enzymes.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com

Contacts
Allison Kurz    
Genedata
Marketing & Communications
Phone: +41 61 511 8459    
communications(at)genedata(dot)com

Jackie Thrasivoulos
Genedata
Public Relations
Phone: +1 508 881 3109
jackie.thrasivoulos(at)genedata(dot)com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at http://www.prweb.com/releases/AB_Enzymes/Strain_Optimization/prweb10730836.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
2. Global Markets for Enzymes in Industrial Applications
3. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
4. Gevo Doesnt Infringe Butamaxs 017 Patent; Gevo was First to Invent Enzyme in 017 Patent; Gevo has Advanced Beyond That and Now Uses Different Enzymes
5. Science study shows promiscuous enzymes still prevalent in metabolism
6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
7. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
8. Lee Biosolutions Manufactures Enzymes For Determining Alcoholic Liver Disease
9. Blocking digestive enzymes may reverse shock, stop multiorgan failure
10. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
11. New England Cord Blood Bank chooses Sepax 2 from Biosafe as their Cord Blood Processing Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 2016 , ... Global Stem Cells Group, has ... The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, ... , The new GSCG clinic is headed by four prominent Ecuadorian physicians, including ...
(Date:2/10/2016)... NX Prenatal Inc., a US based ... for early warning of adverse pregnancy outcomes, announced ... by Dr. Thomas McElrath of Brigham ... Medicine,s (SMFM) annual meeting held in ... The presentation reported initial positive top-line results regarding ...
(Date:2/10/2016)... 10, 2016  Allergan plc (NYSE: AGN ) ... Brent Saunders , Allergan,s CEO and President, will be ... session at the RBC Capital Markets Healthcare Conference on ... The New York Palace Hotel in New ... live and can be accessed on Allergan,s Investor Relations ...
(Date:2/10/2016)... ... February 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics ... Photonics West conference in San Francisco’s Moscone Center from February 16-18, 2016, and ... , These latest InGaAs PIN diode standard packages feature a TO-46 metal can ...
Breaking Biology Technology:
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
(Date:1/22/2016)... http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced the ... in Retail Sector 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced ...
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
Breaking Biology News(10 mins):